Under the steady state condition, intestinal CD4+ T cell responses are well-balanced with aforementioned pTreg cells and pro-inflammatory T cells, but during inflammatory setting, such as experimental inflammatory bowel disease, colonic CD4+ T cell responses are skewed to proinflammatory T cells producing IFN-γ and IL-17. This evidence concerns the gene CD4 and inflammatory bowel disease.